Table 3.
Multivariate analyses of factors associated with all-cause mortality unadjusted for laboratory examination (n = 4104)
| Variables | OR (95% CI) | P |
|---|---|---|
| Male | 1.302 (1.080–1.571) | 0.006 |
| Age (per 1 year increase) | 1.042 (1.035–1.049) | <0.001 |
| Dialysis duration (3–12 months as referent) | ||
| 3–12 | 0.011 | |
| 13–24 | 1.221 (0.898–1.660) | 0.202 |
| 25–60 | 1.257 (0.956–1.653) | 0.102 |
| 61–120 | 0.915 (0.672–1.247) | 0.575 |
| ≥121 | 0.718 (0.464–1.111) | 0.137 |
| Cause of ESRD (PGN as referent) | ||
| PGN | <0.001 | |
| DN | 2.472 (1.969–3.105) | <0.001 |
| HTN | 1.629 (1.224–2.169) | 0.001 |
| Other/unknown | 0.959 (0.741–1.242) | 0.752 |
| Type of vascular access (AVF as referent) | ||
| AVF | <0.001 | |
| TCC | 1.640 (1.244–2.161) | <0.001 |
| NCC | 0.320 (0.192–0.532) | <0.001 |
| AVG | 1.118 (0.394–3.172) | 0.834 |
| Other/unknown | 0.299 (0.136–0.657) | 0.003 |
| Dialysis time every week | 0.959 (0.915–1.004) | 0.075 |
PGN: Primary glomerulonephritis; DN: Diabetic nephropathy; HTN: Hypertensive nephropathy; AVF: Arteriovenous fistula; TCC: Tunnelled cuffed catheter; NCC: Noncuffed catheter; AVG: Arteriovenous graft; ESRD: End-stage renal disease; OR: Odds ratio; CI: Confidence interval.